Inventor · disambiguated record
Shuyang He
Also filed as: HE SHUYANG
1 granted patent·14 pending applications·6 citations·filing 2009–2023
32Inventor score
Top patents by PatentIndex Score
15 records- 0174US10104880B2Cell composition and methods of making the sameZEITLIN ANDY·Filed 2009·Granted Oct 23, 2018·6 cites·22 claims
- 0266US2023302058A1Treatment of lymphedema and related conditions using placental adherent cellsCELULARITY INC·Filed 2023·Application pending·0 cites
- 0363US2021289769A1Cell composition and methods of making the sameCELULARITY INC·Filed 2021·Application pending·0 cites
- 0463US2025295776A1Cleavage resistant cd16 constructs and uses thereofCELULARITY INC·Filed 2023·Application pending·0 cites
- 0554US2019093081A1Placenta-derived intermediate natural killer (pink) cells for treatment of glioblastomaCELULARITY INC·Filed 2018·Application pending·0 cites
- 0652US2022160787A1Placenta derived adherent cells for improved xenoplantationCELULARITY INC·Filed 2020·Application pending·0 cites
- 0751US2025092363A1Placenta-derived allogeneic car-t cells and uses thereofCELULARITY INC·Filed 2020·Application pending·0 cites
- 0849US2022273716A1Populations of natural killer cells comprising a cd38 chimeric antigen receptorCELULARITY INC·Filed 2020·Application pending·0 cites
- 0949US2022000919A1Placental derived natural killer cells for treatment of coronavirus infectionsCELULARITY INC·Filed 2021·Application pending·0 cites
- 1049US2023355759A1Populations of natural killer cells comprising a cleavage resistant cd16CELULARITY INC·Filed 2020·Application pending·0 cites
- 1148US2019314424A1Treatment of lymphedema and related conditions using placental adherent cellsCELULARITY INC·Filed 2017·Application pending·0 cites
- 1248US2023210909A1Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19)CELULARITY INC·Filed 2021·Application pending·0 cites
- 1347US2019261623A1Cell composition and methods of making the sameCELULARITY INC·Filed 2018·Application pending·0 cites
- 1446US2023181649A1Exosomes for disease treatmentCELULARITY INC·Filed 2020·Application pending·0 cites
- 1545US2022265712A1Populations of natural killer cells for treating cancersCELULARITY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuyang He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →